Chandler Ian, Houlston Richard, Landberg Göran
Royal Cancer Hospital Cancer Genetics, Sutton, Surrey, London, UK.
Methods Mol Biol. 2011;675:363-73. doi: 10.1007/978-1-59745-423-0_22.
Tissue microarray (TMA) technology is a robust "high throughput" method of tissue analysis, whereby a large number of patient samples can be examined in a short time using a minimum number of slides. In a TMA, cylinders of tissue are cored out of formalin-fixed, paraffin-embedded tissue blocks and slotted in a regular grid pattern into a blank recipient paraffin wax block. The TMA block is then cut using a standard laboratory microtome. Sections generated are suitable for all in situ techniques, such as immunohistochemistry (IHC) and in situ hybridisation, using essentially the same protocols as are used in conventional sections. The principle advantages of TMAs are that they save valuable biological material and ensure more reproducible reaction conditions while at the same time reducing re-agent costs and laboratory processing. Immunohistochemical studies designed to examine the prognostic utility of TMAs compared with large sections have generally found that they are comparable.
组织微阵列(TMA)技术是一种强大的“高通量”组织分析方法,通过该方法可以使用最少数量的载玻片在短时间内检查大量患者样本。在TMA中,从福尔马林固定、石蜡包埋的组织块中取出组织圆柱体,然后以规则的网格模式插入空白的受体石蜡块中。然后使用标准实验室切片机切割TMA块。生成的切片适用于所有原位技术,如免疫组织化学(IHC)和原位杂交,使用与常规切片基本相同的方案。TMA的主要优点是它们节省了宝贵的生物材料,确保了更可重复的反应条件,同时降低了试剂成本和实验室处理成本。旨在研究TMA与大片段相比的预后效用的免疫组织化学研究通常发现它们具有可比性。